Atorvastatin ameliorates diabetic nephropathy through inhibiting oxidative stress and ferroptosis signaling.
-
Published:2024-08
Issue:
Volume:976
Page:176699
-
ISSN:0014-2999
-
Container-title:European Journal of Pharmacology
-
language:en
-
Short-container-title:European Journal of Pharmacology
Author:
Zhang Yaoxia,
Qu Yuanyuan,
Cai Ruiping,
Gao Junjia,
Xu Qian,
Zhang Lu,
Kang Mengjie,
Jia Hui,
Chen QingORCID,
Liu Yueyang,
Ren Fu,
Zhou Ming-Sheng
Reference61 articles.
1. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal;Ayala;Oxid. Med. Cell. Longev.,2014
2. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial;Baigent;Lancet,2011
3. Statins, mortality, and major Adverse cardiovascular events Among US Veterans with chronic kidney disease;Barayev;JAMA Netw. Open,2023
4. Dyslipidemia in patients with type 2 diabetes. relationships between lipids, kidney disease and cardiovascular disease;Battisti;Clin. Chem. Lab. Med.,2003
5. Non-lipid-related effects of statins;Bellosta;Ann. Med.,2000